JP2021512046A5 - - Google Patents

Download PDF

Info

Publication number
JP2021512046A5
JP2021512046A5 JP2020527111A JP2020527111A JP2021512046A5 JP 2021512046 A5 JP2021512046 A5 JP 2021512046A5 JP 2020527111 A JP2020527111 A JP 2020527111A JP 2020527111 A JP2020527111 A JP 2020527111A JP 2021512046 A5 JP2021512046 A5 JP 2021512046A5
Authority
JP
Japan
Prior art keywords
cancer
optionally
optionally substituted
pharmaceutically acceptable
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020527111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512046A (ja
JP7353281B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061250 external-priority patent/WO2019099646A1/en
Publication of JP2021512046A publication Critical patent/JP2021512046A/ja
Publication of JP2021512046A5 publication Critical patent/JP2021512046A5/ja
Priority to JP2023122183A priority Critical patent/JP2023156359A/ja
Application granted granted Critical
Publication of JP7353281B2 publication Critical patent/JP7353281B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020527111A 2017-11-15 2018-11-15 大環状化合物およびそれらの使用 Active JP7353281B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023122183A JP2023156359A (ja) 2017-11-15 2023-07-27 大環状化合物およびそれらの使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762586416P 2017-11-15 2017-11-15
US62/586,416 2017-11-15
US201862765310P 2018-08-20 2018-08-20
US62/765,310 2018-08-20
PCT/US2018/061250 WO2019099646A1 (en) 2017-11-15 2018-11-15 Macrocyclic compounds and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023122183A Division JP2023156359A (ja) 2017-11-15 2023-07-27 大環状化合物およびそれらの使用

Publications (3)

Publication Number Publication Date
JP2021512046A JP2021512046A (ja) 2021-05-13
JP2021512046A5 true JP2021512046A5 (enExample) 2021-12-23
JP7353281B2 JP7353281B2 (ja) 2023-09-29

Family

ID=64664436

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020527111A Active JP7353281B2 (ja) 2017-11-15 2018-11-15 大環状化合物およびそれらの使用
JP2023122183A Pending JP2023156359A (ja) 2017-11-15 2023-07-27 大環状化合物およびそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023122183A Pending JP2023156359A (ja) 2017-11-15 2023-07-27 大環状化合物およびそれらの使用

Country Status (6)

Country Link
US (3) US11407762B2 (enExample)
EP (2) EP4403560A3 (enExample)
JP (2) JP7353281B2 (enExample)
CN (2) CN111566113B (enExample)
ES (1) ES2974243T3 (enExample)
WO (1) WO2019099646A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
JP7168580B2 (ja) * 2017-04-05 2022-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびその使用
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
IL295588B2 (en) 2017-07-06 2024-03-01 Harvard College Synthesis of halichondrins
ES2974243T3 (es) * 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK187280A (da) 1980-04-30 1981-10-31 Novo Industri As Ruhedsreducerende middel til et fuldvaskemiddel fuldvaskemiddel og fuldvaskemetode
JPS61191687A (ja) 1985-02-20 1986-08-26 Fujisawa Pharmaceut Co Ltd ハリコンドリンb
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
DE4229425A1 (de) 1992-09-03 1994-03-10 Kodak Ag Vorrichtung zum stapelweisen Ablegen und Ausrichten von einzeln zugeführten Blättern
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
JP2818381B2 (ja) 1994-01-18 1998-10-30 帝人株式会社 7−チアプロスタグランジン類およびその製造法
US5519050A (en) * 1995-04-07 1996-05-21 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of halistatin 3
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
IL139960A0 (en) 1998-06-17 2002-02-10 Eisai Co Ltd Macrocylic analogs and methods of their use and preparation
US8097648B2 (en) * 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
JP2001305734A (ja) 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
CN101899026B (zh) 2004-06-03 2016-08-03 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
WO2006076100A2 (en) 2004-12-09 2006-07-20 Eisai Co. Ltd. Tubulin isotype screening in cancer therapy using halichondrin b analogs
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
BRPI0808252A2 (pt) 2007-03-07 2014-07-01 Interdigital Tech Corp Método e dispositivo para que se gere e se processe uma unidade de dados de protocolo mac-ehs.
CN101918844A (zh) 2007-06-18 2010-12-15 米迪缪尼有限公司 表达epha2和erbb2的细胞的协同治疗
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
JP5134686B2 (ja) 2007-11-16 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンbアナログ合成のための新規な中間体及び前記中間体に用いるための新規な脱スルホニル化反応
JP6001857B2 (ja) 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
BR112012018232B8 (pt) 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
EP2663337A4 (en) 2011-01-10 2014-06-11 Harvard College METHOD OF DELIVERING AGENTS IN CELLS BY BACTERIAL TOXINE
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
EP2791123B1 (en) 2011-12-16 2018-07-18 Sandoz AG Process for preparation of 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
AU2012363334B2 (en) 2011-12-29 2017-02-02 Alphora Research Inc. 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl) tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
CN104334562A (zh) 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
WO2014183211A1 (en) 2013-05-15 2014-11-20 Alphora Research Inc. 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
AU2014286880B2 (en) 2013-07-03 2017-12-14 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing -SO2-(p-TOLYL) groups
HUE049387T2 (hu) 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
SG10201805024YA (en) 2013-12-06 2018-07-30 Eisai R&D Man Co Ltd Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016038624A1 (en) 2014-09-09 2016-03-17 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX380284B (es) 2015-05-07 2025-03-12 Eisai R&D Man Co Ltd Reacciones de macrociclización e intermediarios y otros fragmentos útiles en la síntesis de macrólidos de halicondrina.
JOP20170053B1 (ar) 2016-03-02 2021-08-17 Eisai Randd Man Co Ltd مترافقات جسم مضاد وعقار أساسها إيريبولين وطرق استخدامها
WO2018008667A1 (ja) 2016-07-07 2018-01-11 新日本理化株式会社 動力伝達用潤滑油基油
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
SG11201907217RA (en) 2017-02-20 2019-09-27 Polyphor Ag Pharmaceutical combinations for treating cancer
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
JP7168580B2 (ja) * 2017-04-05 2022-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびその使用
JP2019013861A (ja) 2017-07-03 2019-01-31 住友化学株式会社 ガス分離膜エレメント、ガス分離膜モジュール、及びガス分離装置
WO2019009956A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College SUMMARY OF MEDIUM MEDIATED KETONE
US20230135188A1 (en) 2017-07-06 2023-05-04 President And Fellows Of Harvard College Fe/cu-mediated ketone synthesis
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
IL295588B2 (en) * 2017-07-06 2024-03-01 Harvard College Synthesis of halichondrins
ES2974243T3 (es) 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2021512046A5 (enExample)
JP2018504418A5 (enExample)
TWI789700B (zh) 抗體-藥物結合物
JP2019501204A5 (enExample)
JP2011519941A5 (enExample)
JP2024178243A (ja) 抗体-薬物コンジュゲートとチューブリン阻害剤の組み合わせ
JP2017510661A5 (enExample)
JP2016166203A5 (enExample)
JP6425653B2 (ja) 抗腫瘍剤及び抗腫瘍効果増強剤
JP2018537975A5 (enExample)
IL276514B2 (en) Glypican 3 antibodies and conjugates thereof
JP2006519862A5 (enExample)
RU2013155455A (ru) Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6
JP2010535713A5 (enExample)
RU2005136222A (ru) Противоопухолевые комбинации
RU2020113749A (ru) Аналоги таиланстатина
JPWO2019214634A5 (enExample)
JP2019524714A5 (enExample)
JPWO2021260579A5 (enExample)
JP2016540826A5 (enExample)
JPWO2021263026A5 (enExample)
CN119300868B (zh) 喜树碱类化合物及其偶联物、其制备方法和用途
JPWO2020204033A5 (enExample)
RU2019135531A (ru) Макроциклическое соединение и его применения
CN120957726A (zh) 抗体-药物偶联物与癌症疗法的组合及其用途